National osteoporosis society vitamin D Guideline Summary

Age and Ageing

Volumn 43, Issue 5, 2014, Pages 592-595

  Aspray, Terry J ^a,b   Bowring, Claire ^c   Fraser, William ^d   Gittoes, Neil ^e   Javaid, M Kassim ^f   Macdonald, Helen ^g   Patel, Sanjeev ^h   Selby, Peter ⁱ   Tanna, Nuttan ^j   Francis, Roger M ^b  

^a FREEMAN HOSPITAL   (United Kingdom)

^b NEWCASTLE UNIVERSITY   (United Kingdom)

^c NATIONAL OSTEOPOROSIS SOCIETY   (United Kingdom)

^d UNIVERSITY OF EAST ANGLIA   (United Kingdom)

^e UNIVERSITY HOSPITALS BIRMINGHAM NHS FOUNDATION TRUST   (United Kingdom)

^f UNIVERSITY OF OXFORD   (United Kingdom)

^g UNIVERSITY OF ABERDEEN   (United Kingdom)

^h EPSOM AND ST HELIER UNIVERSITY HOSPITALS NHS TRUST   (United Kingdom)

ⁱ MANCHESTER ROYAL INFIRMARY   (United Kingdom)

^j NATIONAL HEALTH SERVICE   (United Kingdom)

more..

Author keywords

Muscle and vitamin D; Osteomalacia; Vitamin D deficiency; Vitamin D deficiency threshold; Vitamin D testing older people

Indexed keywords

25-HYDROXYVITAMIN D; BIOLOGICAL MARKER; BONE DENSITY CONSERVATION AGENT; COLECALCIFEROL; VITAMIN D; 25 HYDROXYVITAMIN D; ALBUMIN; CALCIUM; ERGOCALCIFEROL;

ANALOGS AND DERIVATIVES; BLOOD; DIETARY REFERENCE INTAKE; DIETARY SUPPLEMENT; HUMAN; ORAL DRUG ADMINISTRATION; OSTEOPOROSIS; PRACTICE GUIDELINE; PREDICTIVE VALUE; REPRODUCIBILITY; RISK FACTOR; TREATMENT OUTCOME; VITAMIN D DEFICIENCY; ADVERSE OUTCOME; ALBUMIN BLOOD LEVEL; ARTICLE; BONE DENSITY; CALCIUM BLOOD LEVEL; CANCER PREVENTION; CARDIOVASCULAR RISK; FRACTURE; IMMUNOMODULATION; LOADING DRUG DOSE; MAINTENANCE THERAPY; MALABSORPTION; NONHUMAN; NUTRITIONAL STATUS; OSTEOMALACIA; OUTCOME ASSESSMENT; PRIMARY HYPERPARATHYROIDISM; RISK ASSESSMENT; SECONDARY HYPERPARATHYROIDISM; VITAMIN BLOOD LEVEL; VITAMIN SUPPLEMENTATION;

ADMINISTRATION, ORAL; BIOMARKERS; BONE DENSITY CONSERVATION AGENTS; CHOLECALCIFEROL; DIETARY SUPPLEMENTS; HUMANS; OSTEOPOROSIS; PREDICTIVE VALUE OF TESTS; RECOMMENDED DIETARY ALLOWANCES; REPRODUCIBILITY OF RESULTS; RISK FACTORS; TREATMENT OUTCOME; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 84906883825     PISSN: 00020729     EISSN: 14682834     Source Type: Journal    
DOI: 10.1093/ageing/afu093     Document Type: Article

References (17)

1. Rosen CJ, Adams JS, Bikle DD et al. The non-skeletal effects of vitamin D: an endocrine society scientific statement. Endocr Rev 2012; 33: 456-92. doi:10.1210/er.2012-1000.
2. Hirani V, Primatesta P. Vitamin D concentrations among people aged 65 years and over living in private households and institutions in England: population survey. Age Ageing 2005; 34: 485-91. doi:10.1093/ageing/afi153.
3. Ross AC, Institute of Medicine (U. S.). Committee to Review Dietary Reference Intakes for Vitamin D and Calcium. DRI, Dietary Reference Intakes: Calcium, Vitamin D. Washington, DC: National Academies Press, 2011.
4. Holick MF, Binkley NC, Bischoff-Ferrari HA et al. Evaluation, treatment, and prevention of vitamin D deficiency: an endocrine society clinical practice guideline. J Clin Endocrinol Metabol 2011; 96: 1911-30.
5. Tangpricha V, Kelly A, Stephenson A et al. An update on the screening, diagnosis, management, and treatment of vitamin D deficiency in individuals with cystic fibrosis: evidence-based recommendations from the Cystic Fibrosis Foundation. J Clin Endocrinol Metabol 2012; 97: 1082-93. doi:10.1210/ jc.2011-3050.
6. Perez-Lopez FR, Brincat M, Erel CT et al. EMAS position statement: vitamin D and postmenopausal health. Maturitas 2012; 71: 83-8. doi:10.1016/j.maturitas. 2011.11.002.
7. Adami S, Romagnoli E, Carnevale V et al. Guidelines on prevention and treatment of vitamin D deficiency. Reumatismo 2011; 63: 129-47. doi:10.4081/reumatismo. 2011.129.
8. Kulie T, Groff A, Redmer J et al. Vitamin D: an evidencebased review. J Am Board Family Med 2009; 22: 698-706. doi:10.3122/jabfm.2009.06.090037.
9. Cranney A. Effectiveness and Safety of Vitamin D in Relation to Bone Health. Rockville, MD: U.S. Dept. of Health and Human Services, Public Health Service, Agency for Healthcare Research and Quality, 2007.
10. Chung M, Balk EM, Brendel M et al. Vitamin D and calcium: a systematic review of health outcomes. Evidence report/technology assessment. Evid Rep Technol Assess (Full Rep). 2009; 183: 1-420.
11. Fraser WD, Milan AM. Vitamin D assays: past and present debates, difficulties, and developments. Calcif Tissue Int 2013; 92: 118-27. doi:10.1007/s00223-012-9693-3.
12. Vieth R. Why the minimum desirable serum 25-hydroxyvitamin D level should be 75 nmol/l (30 ng/ml). Best Practice Res: Clin Endocrinol Metabol 2011; 25: 681-91.
13. Tripkovic L, Lambert H, Hart K et al. Comparison of vitamin D2 and vitamin D3 supplementation in raising serum 25-hydroxyvitamin D status: a systematic review and metaanalysis. Am J Clin Nutr 2012; 95: 1357-64. doi:10.3945/ ajcn.111.031070.
14. Pearce SH, Cheetham TD. Diagnosis and management of vitamin D deficiency. BMJ 2010; 340: b5664. doi:10.1136/ bmj.b5664.
15. Sanders KM, Stuart AL, Williamson EJ et al. Annual high-dose oral vitamin D and falls and fractures in older women: a randomized controlled trial. JAMA 2010; 303: 1815-22. doi:10.1001/jama.2010.594.
16. Law M, Withers H, Morris J et al. Vitamin D supplementation and the prevention of fractures and falls: results of a randomised trial in elderly people in residential accommodation. Age Ageing 2006; 35: 482-6. doi:10.1093/ageing/afj080.
17. Smith H, Anderson F, Raphael H et al. Effect of annual intramuscular vitamin D on fracture risk in elderly men and women-a population-based, randomized, double-blind, placebo-controlled trial. Rheumatology (Oxford) 2007; 46: 1852-7. doi: 10.1093/rheumatology/kem240.